Selected research
Industry Growth & Trends
Global Antithrombin Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Antithrombin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Antithrombin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Antithrombin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Antithrombin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Antithrombin market include Takeda, Scripps Laboratories Inc., Grifols, rEVO Biologics Inc., Lee Biosolutions, Kedrion S.p.A. and CSL Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Antithrombin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Antithrombin market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antithrombin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antithrombin.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Antithrombin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Antithrombin Market by Company
Takeda
Scripps Laboratories Inc.
Grifols
rEVO Biologics Inc.
Lee Biosolutions
Kedrion S.p.A.
CSL Limited
Antithrombin Segment by Type
Liquid
Lyophilized
Antithrombin Segment by Application
Diagnostics
Research
Therapeutics
Antithrombin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antithrombin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antithrombin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antithrombin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Antithrombin companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Liquid
- Lyophilized
Applications
- Diagnostics
- Research
- Therapeutics
Companies covered
- Takeda
- Scripps Laboratories Inc.
- Grifols
- rEVO Biologics Inc.
- Lee Biosolutions
- Kedrion S.p.A.
- CSL Limited
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Antithrombin Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Antithrombin Market Size by Region (2021-2032)
- 1.4.1 Global Antithrombin Market Size by Region (2021-2026)
- 1.4.2 Global Antithrombin Market Size by Region (2027-2032)
- 1.5 Key Regions Antithrombin Market Size (2021-2032)
- 1.5.1 North America Antithrombin Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Antithrombin Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Antithrombin Market Size Growth Rate (2021-2032)
- 1.5.4 South America Antithrombin Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Antithrombin Market Size Growth Rate (2021-2032)
2 Antithrombin Market by Type
- 2.1 Type Introduction
- 2.1.1 Liquid
- 2.1.2 Lyophilized
- 2.2 Global Antithrombin Market Size by Type
- 2.2.1 Global Antithrombin Market Size Overview by Type (2021-2032)
- 2.2.2 Global Antithrombin Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Antithrombin Market Size Forecasted by Type (2027-2032)
- 2.3 Global Antithrombin Market Size by Regions
- 2.3.1 North America Antithrombin Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Antithrombin Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Antithrombin Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Antithrombin Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Antithrombin Market Size Breakdown by Type (2021-2026)
3 Antithrombin Market by Application
- 3.1 Type Introduction
- 3.1.1 Diagnostics
- 3.1.2 Research
- 3.1.3 Therapeutics
- 3.2 Global Antithrombin Market Size by Application
- 3.2.1 Global Antithrombin Market Size Overview by Application (2021-2032)
- 3.2.2 Global Antithrombin Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Antithrombin Market Size Forecasted by Application (2027-2032)
- 3.3 Global Antithrombin Market Size by Regions
- 3.3.1 North America Antithrombin Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Antithrombin Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Antithrombin Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Antithrombin Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Antithrombin Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Antithrombin Industry Trends
- 4.2 Antithrombin Industry Drivers
- 4.3 Antithrombin Industry Opportunities and Challenges
- 4.4 Antithrombin Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Antithrombin Revenue (2021-2026)
- 5.2 Global Antithrombin Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Antithrombin Key Company Headquarters & Area Served
- 5.4 Global Antithrombin Company, Product Type & Application
- 5.5 Global Antithrombin Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Antithrombin Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Antithrombin Players Market Share by Revenue in 2025
- 5.6.3 2025 Antithrombin Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Takeda
- 6.1.1 Takeda Company Information
- 6.1.2 Takeda Business Overview
- 6.1.3 Takeda Antithrombin Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Takeda Antithrombin Product Portfolio
- 6.1.5 Takeda Recent Developments
- 6.2 Scripps Laboratories Inc.
- 6.2.1 Scripps Laboratories Inc. Company Information
- 6.2.2 Scripps Laboratories Inc. Business Overview
- 6.2.3 Scripps Laboratories Inc. Antithrombin Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Scripps Laboratories Inc. Antithrombin Product Portfolio
- 6.2.5 Scripps Laboratories Inc. Recent Developments
- 6.3 Grifols
- 6.3.1 Grifols Company Information
- 6.3.2 Grifols Business Overview
- 6.3.3 Grifols Antithrombin Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Grifols Antithrombin Product Portfolio
- 6.3.5 Grifols Recent Developments
- 6.4 rEVO Biologics Inc.
- 6.4.1 rEVO Biologics Inc. Company Information
- 6.4.2 rEVO Biologics Inc. Business Overview
- 6.4.3 rEVO Biologics Inc. Antithrombin Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 rEVO Biologics Inc. Antithrombin Product Portfolio
- 6.4.5 rEVO Biologics Inc. Recent Developments
- 6.5 Lee Biosolutions
- 6.5.1 Lee Biosolutions Company Information
- 6.5.2 Lee Biosolutions Business Overview
- 6.5.3 Lee Biosolutions Antithrombin Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Lee Biosolutions Antithrombin Product Portfolio
- 6.5.5 Lee Biosolutions Recent Developments
- 6.6 Kedrion S.p.A.
- 6.6.1 Kedrion S.p.A. Company Information
- 6.6.2 Kedrion S.p.A. Business Overview
- 6.6.3 Kedrion S.p.A. Antithrombin Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Kedrion S.p.A. Antithrombin Product Portfolio
- 6.6.5 Kedrion S.p.A. Recent Developments
- 6.7 CSL Limited
- 6.7.1 CSL Limited Company Information
- 6.7.2 CSL Limited Business Overview
- 6.7.3 CSL Limited Antithrombin Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 CSL Limited Antithrombin Product Portfolio
- 6.7.5 CSL Limited Recent Developments
7 North America
- 7.1 North America Antithrombin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Antithrombin Market Size by Country (2021-2026)
- 7.3 North America Antithrombin Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Antithrombin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Antithrombin Market Size by Country (2021-2026)
- 8.3 Europe Antithrombin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Antithrombin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Antithrombin Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Antithrombin Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Antithrombin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Antithrombin Market Size by Country (2021-2026)
- 10.3 South America Antithrombin Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Antithrombin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Antithrombin Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Antithrombin Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst